EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roques, F.
Right arrow Articles by Thulin, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roques, F.
Right arrow Articles by Thulin, L.

Eur J Cardiothorac Surg 1999;15:816-823
© 1999 Elsevier Science NL


Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients

F. Roques, S.A.M. Nashef, P. Michel, E. Gauducheau, C. de Vincentiis, E. Baudet, J. Cortina, M. David, A. Faichney, F. Gavrielle, E. Gams, A. Harjula, M.T. Jones, P. Pinna Pintor, R. Salamon, L. Thulin

Service de chirurgie cardiovasculaire, CHU de Fort de France, 97200Martinique, France

Received 22 September 1998; received in revised form 8 March 1999; accepted 11 March 1999.

Corresponding author. Tel.: +596-552271; fax: +596-758438; email: f.r.fwi@wanadoo.fr


    Abstract
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 Appendices A - I
 Appendix J. Conference...
 References
 
Objective: To assess risk factors for mortality in cardiac surgical adult patients as part of a study to develop a European System for Cardiac Operative Risk Evaluation (EuroSCORE). Methods: From September to November 1995, information on risk factors and mortality was collected for 19030 consecutive adult patients undergoing cardiac surgery under cardiopulmonary bypass in 128 surgical centres in eight European states. Data were collected for 68 preoperative and 29 operative risk factors proven or believed to influence hospital mortality. The relationship between risk factors and outcome was assessed by univariate and logistic regression analysis. Results: Mean age (± standard deviation) was 62.5±10.7 (range 17–94 years) and 28% were female. Mean body mass index was 26.3±3.9. The incidence of common risk factors was as follows: hypertension 43.6%, diabetes 16.7%, extracardiac arteriopathy 2.9%, chronic renal failure 3.5%, chronic pulmonary disease 3.9%, previous cardiac surgery 7.3% and impaired left ventricular function 31.4%. Isolated coronary surgery accounted for 63.6% of all procedures, and 29.8% of patients had valve operations. Overall hospital mortality was 4.8%. Coronary surgery mortality was 3.4% In the absence of any identifiable risk factors, mortality was 0.4% for coronary surgery, 1% for mitral valve surgery, 1.1% for aortic valve surgery and 0% for atrial septal defect repair. The following risk factors were associated with increased mortality: age (P=0.001), female gender (P=0.001), serum creatinine (P=0.001), extracardiac arteriopathy (P=0.001), chronic airway disease (P=0.006), severe neurological dysfunction (P=0.001), previous cardiac surgery (P=0.001), recent myocardial infarction (P=0.001), left ventricular ejection fraction (P=0.001), chronic congestive cardiac failure (P=0.001), pulmonary hypertension (P=0.001), active endocarditis (P=0.001), unstable angina (P=0.001), procedure urgency (P=0.001), critical preoperative condition (P=0.001) ventricular septal rupture (P=0.002), non-coronary surgery (P=0.001), thoracic aortic surgery (P=0.001). Conclusion: A number of risk factors contribute to cardiac surgical mortality in Europe. This information can be used to develop a risk stratification system for the prediction of hospital mortality and the assessment of quality of care.

Key Words: Risk factors • EuroSCORE database


    1. Introduction
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 Appendices A - I
 Appendix J. Conference...
 References
 
As a result of continually improving surgical strategy and the technology which supports it, cardiac surgery is now possible in an increasingly high-risk population [1]. Crude mortality rates have often been used as an indicator of quality of care, but their value is limited without knowledge of the risk profile of the patients. Little is known about the current risk profile of the European cardiac surgical patients. Some European states have access to procedural cardiac surgical mortality rates but these are usually not related to preoperative risk factors. We embarked on this study with a view to establish the risk profile of adult cardiac surgical patients and determine the procedural mortality in these patients. The large multinational database of this project will then serve to develop the European System for Cardiac Operative Risk Evaluation (EuroSCORE).


    2. Methods
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 Appendices A - I
 Appendix J. Conference...
 References
 
2.1. Project setup
A multinational project steering group was set up to include a number of European cardiac surgeons and epidemiologists with an interest in the field of cardiac surgical risk (Euroscore study group: Appendix A). The findings of preliminary studies by members of the group [2,3], and the features of predominantly North American risk models, their refinements and their application [414] were considered and analysed. Consequently, 68 preoperative and 29 operative risk factors were selected and defined on the basis of credibility, objectivity, reliability and prevalence. These risk factors and definitions are detailed in Appendices B–H.

2.2. Data collection
A simple data collection form was then designed so that information on these risk factors could be entered easily on one side of A4 size paper. Comprehensive information on data collection requirements and definitions of variables was provided to all participating institutions and summarized on detachable sections on every data collection form. Mortality was defined as death within 30 days of operation or within the same hospital admission (Appendix I). To preserve confidentiality, patient and centre identification was coded. Members of the steering committee acted as national organizers to supervise and coordinate centre recruitment and data collection in participating countries. Recruitment was on a voluntary basis. Data collection was carried out over three months (September–December 1995). All adult patients who underwent cardiac surgery under cardiopulmonary bypass during this period were included in the study.

2.3. Data entry
Data were gathered and entered onto a computer database at the biostatistical research centre of the University of Bordeaux, France. In order to ensure the highest possible quality of data entry, all data were entered twice independently by two operators and any discrepancies checked and corrected. The database was subjected to 16 out-of-range error checking operations and a further 16 separate operations were used to identify errors of logic. Incomplete forms were identified by the absence of information in any of 10 mandatory fields. Erroneous and incomplete data collection forms thus identified were returned to the participating centres for correction and completion. At the end of this procedure, centres whose data did not reach the preset target of >99% for accuracy and completeness of mandatory fields were removed from the study.

2.4. Analysis
The statistical model was multiple logistic regression. The variables entered in the model were selected using bivariate tests, chi square tests for categorical covariates and unpaired t-tests or Wilcoxon rank sum tests for continuous covariates. All variables significant at the P<0.2 level were entered into the model provided they were present in at least 2% of the sample. Non-significant variables were eliminated from the model one at a time, beginning with the variable having the highest P-value. Stability of the model was checked every time a variable was eliminated. In the case of continuous variables where the relationship with outcome was not linear, such as serum creatinine, we determined cut-off points using the fractional polynomials method. When all statistically non-significant variables had been eliminated from the model, goodness-of-fit testing was used to assess how well the model was calibrated and the area under the receiver operating characteristic (ROC) curve was used to assess how well the model could discriminate between patients who lived and patients who died.


    3. Results
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 Appendices A - I
 Appendix J. Conference...
 References
 
In all, 132 centres from 8 European countries participated in the project, giving a total of 20014 patients. National patient and centre distribution is detailed in Table 1. Following the error checking and quality control procedures described above, four centres were eliminated from the study, leaving 19030 patients for analysis.


View this table:
[in this window]
[in a new window]
 
Table 1. National patient and centre distribution. Data collection was organized separately for England (11 centres, 2774 patients) and Scotland (four centres, 819 patients).

 
3.1. Patient characteristics
The mean age of the patients was 62.5 with a standard deviation of 10.7. Age range was 17–94 years, 10% of patients were aged 75 or over and 28% were female. Mean body mass index was 26.3±3.9 with a range of 12 to 68. and 5% of patients can be classified as morbidly obese with a body mass index of 33 or over. Systolic arterial blood pressure exceeded 140 in 25% of patients and diastolic pressure exceeded 90 in 10%. A history of hypertension was elicited from 44% of patients. Diabetes was present in 17% distributed as follows: 4% on insulin, 8.5% on oral therapy and the rest on diet control.

3.2. Vascular disease
Evidence of extracardiac arteriopathy as defined in Appendix C was present in 11% of patients: 2.9% had already undergone vascular surgery and in 1.3% such surgery was planned for the future. Intermittent claudication affected 5.8% of patients. Carotid disease was present in 4.4% and was bilateral in one third. Abdominal aortic disease was present in 1.3%. There was some overlap between the above categories because of the presence of generalized arteriopathy in some patients.

3.3. Renal and respiratory function
Mean serum creatinine was 103 µmol/l with 5% of patients exceeding 150 µmol/l. A diagnosis of chronic renal insufficiency was established in 3.5% but only 0.5% were on long-term dialysis treatment. Chronic pulmonary disease, defined by the long-term use of bronchodilators and steroids, affected 3.9% of patients.

3.4. General cardiac status
Previous cardiac surgery had been carried out in 7.2% of patients of whom 85% had one previous operation, 10% had two and 5% had three or more. Chronic cardiac insufficiency was present in 13.7% of patients, with 5.8% in NYHA class IV. Atrial fibrillation was present in 9%. Left ventricular (LV) function was normal in 61% of patients with an ejection fraction (EF) of 50% or more, moderate in 32% (EF 30–50%) and poor in 7% (EF<30%).

3.5. Cardiac status of coronary patients
In patients undergoing isolated coronary surgery, 15% had a myocardial infarction within the preceding 3 months with a mean interval of 35 days. Rest pain was present in 21% of patients and 12% were unstable to the extent of needing intravenous nitrate therapy. Emergency surgery for catheter laboratory complications accounted for 1% of all procedures. Two thirds of coronary patients had triple vessel disease, a quarter had double vessel disease and only 8% single vessel disease. Left main stem stenosis (>50%) was present in 22% of patients and very tight (>90%) in 5.3%.

3.6. Cardiac status of valve patients
In mitral valve surgery, the valve lesion was regurgitation in 58%, stenosis in 26% and both in 16%. Pulmonary artery systolic pressure exceeded 60 mmHg in 16.5% of mitral patients. In aortic valve surgery, the proportions were reversed with stenosis being the predominant lesion (55%) over regurgitation (27%) and mixed lesions (18%). In aortic stenosis the systolic gradient across the valve exceeded 120 mmHg in 8% of patients. Active endocarditis was present in 202 (3.6%) of all valve patients.

3.7. Other variables
Critical preoperative conditions affected 774 (4%) of patients and are summarized in Table 2. Rare conditions which may contribute to risk were identified in 737 patients (3.9%) and are detailed in Table 3.


View this table:
[in this window]
[in a new window]
 
Table 2. Critical preoperative conditions. These are defined in detail in Appendix E.

 

View this table:
[in this window]
[in a new window]
 
Table 3. Rare preoperative conditions. These are defined in detail in Appendix F.

 
3.8. Operations
Elective surgery accounted for 74% of procedures, with 21% and 5% being urgent or emergent as defined in Appendix G. Isolated coronary surgery was performed in 65% of patients and 29.4% had valve procedures. Two thirds of coronary patients had three or more distal anastomoses, 25% had two and only 9% had one. Aortic valve surgery accounted for 57% of valve procedures, mitral repair or replacement 29% and double valve procedures 14%. There were 489 (2.6%) operations on the thoracic aorta of which a third involved the aortic root and 18% the aortic arch. Atrial septal defect repair accounted for 236 procedures (1.2%) and there were 136 heart transplants.

3.9. Mortality
Overall cardiac surgical mortality for all procedures was 4.8%. Table 4 illustrates the overall procedural mortality as well as the baseline mortality for patients without any identifiable risk factors whether significant or not.


View this table:
[in this window]
[in a new window]
 
Table 4. Procedural mortality overall and in the absence of any risk factors (95% confidence intervals in brackets)

 
3.10. Risk factors analysis
Multivariate analysis identified a number of risk factors to be related to operative mortality. These are detailed in Table 5. The calibration of the model was satisfactory and the discrimination power was very good (area under ROC curve 0.79).


View this table:
[in this window]
[in a new window]
 
Table 5. Determinants of operative mortality for adult patients undergoing open heart surgery

 

    4. Discussion
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 Appendices A - I
 Appendix J. Conference...
 References
 
The changing risk profile in cardiac surgical patients over the past decade means that crude procedural mortality figures are no longer sufficient either for informed consent by patients or for the assessment of the quality of care in institutions. It is sometimes argued that crude mortality may suffice for quality of care measurement as it also reflects the wisdom of careful patient selection. This is fallacious in cardiac surgery because of the risk paradox: it has been shown that it is particularly in high risk patients that the superiority of surgical over medical treatment is most pronounced [15]. It is also argued by some that operative mortality is not the only important outcome measure, that patients who survive cardiac operations may still have high morbidity and a poor long-term outcome [16,17]. Although this argument is undoubtedly true, its impact is much weakened by the fact that both postoperative morbidity and poor late results largely stem from failure to achieve a satisfactory cardiac outcome, itself the primary reason for operative mortality. In other words, low early mortality is likely to be associated with low morbidity and good long-term results. Therefore, relating mortality to risk remains the mainstay of any system that assesses the quality of cardiac surgical care.

There have been many studies of risk-factors in cardiac surgery [214]. Most were derived from the North American patient population and may not necessarily apply to European practice. This study was undertaken to produce a reliable and contemporary European risk profile for cardiac surgery. Entry to the study was voluntary. This necessarily means that centres which agreed to participate were self selected. We accept that this inevitably leads to a degree of bias, but the alternative approach of random selection followed by compulsion would have been associated with two larger problems. The first is that of non-compliance leading to incomplete data collection. The second and worse problem is possible scepticism or malevolence towards the project leading to unreliable data, wrong results and erroneous conclusions. We believe that the excellent compliance and high degree of data accuracy that we obtained justifies the voluntary enrolment approach. Accuracy and completeness were further enhanced by three features of the study design: considerable time and effort were invested in the preparation of a brief, user-friendly and unambiguous data collection sheet with detailed explanation at the point of use; data collection was ‘short and sweet’ in order to avoid loss of momentum and enthusiasm for the project over time; finally, patient and centre confidentiality were guaranteed.

Many risk factors have been associated with cardiac surgical mortality. Some are preoperative patient characteristics, others are related to the type and severity of the cardiac disease itself and a third group are related to the type and extent of the surgical procedure. Although the risk factors selected for evaluation were largely similar to those in other studies, it will be noted that, whenever possible, objective and simple definitions were provided. Previous studies have stumbled in fields which are either naturally complex, poorly defined or both such as unstable angina, extracardiac arteriopathy and pulmonary disease. We provided simplified definitions and clear subclassifications in order to avoid ambiguity and the loss of potentially valuable information.

This large database has for the first time provided a unique opportunity to assess the true risk of cardiac surgery in the absence of any identifiable risk factors. For the purposes of this analysis, baseline mortality figures were calculated in patients in whom no pre-operative risk factors could be identified (including risk factors which were not found to have a significant impact in this study, such as diabetes and hypertension). When all such patients are excluded, it was gratifying to note the extremely low current mortality for cardiac surgery in Europe: nil for atrial septal defect repair, 0.4% for CABG and barely over 1% for single valve repair or replacement. Many of these ‘near-zero-risk’ patients with coronary disease are currently offered interventional cardiology on the alleged basis of appreciable cardiac surgical mortality. These patients and their physicians may be well advised to reconsider the option of coronary surgery in the light of these results.

Many of the risk factors identified as significant in the multivariate analysis, such as age, sex and left ventricular function have been identified elsewhere [2,4,13,18].The absence of diabetes, hypertension and smoking may surprise some clinicians but this too is supported by other studies [1921]. Two relatively new risk factors figure prominently in our findings: extracardiac arteriopathy and severe neurological dysfunction. Many cardiac surgeons have learnt from experience that these are important determinants of outcome, and this is supported in recent work [2,22]. We believe that our ability convincingly to demonstrate their impact owes much to the simple and objective definitions provided at the data collection stage. The same applies to our definition of chronic airway disease, a condition judged to be too vague for inclusion by other workers [4].

The EuroSCORE database will be used to construct a risk stratification system for use in all European cardiac surgery. It is also a rich and highly accurate database, reflecting a snapshot of cardiac surgery in the 1990s, and will be subjected to further analysis in order to determine demographic, regional and procedural variations in European cardiac surgery.


    Acknowledgments
 
The authors wish to thank St Jude Medical and Bard for their financial support to the EuroSCORE project. We are grateful to Mrs Helen Rodriquez for administering the data collection and to the European Club of Young Cardiac Surgeons for general support in the implementation of this venture. Finally, we wish to recognize the important efforts of the physicians and other health workers who cooperated and contributed to the data collection in every one of the 132 participating hospitals across Europe, without whom this project would not have been possible.


    Footnotes
 
Presented at the 12th Annual Meeting of the European Association for Cardio-thoracic Surgery, Brussels, Belgium, September 20–23, 1998.


    Appendices A - I
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 Appendices A - I
 Appendix J. Conference...
 References
 
Appendix A. EuroSCORE study group
E Baudet, J Cortina, M David, A Faichney, F Gabrielle, E Gams, E Gauducheau, A Harjula, MT Jones, P Michel, SAM Nashef, P Pinna Pintor, F Roques, R Salamon, L Thulin, C de Vincentiis.

Appendix B. General patient information
Go

Variable


Definition


Age in years at last birthday
Sex
Weight in kilograms
Height in centimetres
Haematocrit last preoperative value
Serum creatinine last preoperative value in µmol/l
Blood pressure(systolic and diastolic)

last preoperative value in mmHg

Appendix C. Preoperative general risk factors
Go

Variable


Definition


History of hypertension Patient thinks he or she has a diagnosis of hypertension
Diabetes subdivided into diet-controlled, oral therapy or insulin
Intermittent claudication1 symptom present
Carotid disease(unilateral or bilateral)1 defined as occlusion or >50% stenosis
Previous surgery for vascular disease1 of the abdominal aorta, limb arteries or carotids
Future surgery disease1 already planned surgery of the abdominal aorta, for vascular limb arteries or carotids
Chronic renal failure subdivided into with and without dialysis
Chronic pulmonary disease

defined by the long-term use of bronchodilators or steroids

a Extracardiac arteriopathy was defined as the presence of one or more of these four risks.

Appendix D. Preoperative cardiac risk factors
Go

Variable


Definition


Past cardiac operation (1, 2 or more) any previous cardiac surgery requiring opening the pericardium, but excluding surgery during the current hospitalization
Chronic congestive heart failure chronic or episodic peripheral oedema, pleural effusion or hepatomegaly
Chronic cardiac-related dyspnea at rest NYHA class 4
Atrial fibrillation
Ejection fraction
Echocardiographic shortening fraction
Left ventricular end-diastolic pressure in mmHg
Left ventricular aneurysm whether operated or not
Pacemaker

permanent pacemaker in place at the time of the operation

Appendix E. Critical preoperative situation
Go

Variable


Definition


Ventricular tachycardia or fibrillation preoperative history of ventricular tachycardia, fibrillation or aborted sudden death
Cardiac massage preoperative
Intubated critical preoperative situation needing intubation and ventilation before arrival in the operating room
Intra-aortic balloon pump (IABP) arrival of patient in the operation room with IABP or cardiac assist device
Intravenous inotropic support preoperative
Urine output <10 ml/h

preoperative

Appendix F. Rare general conditions
Go

Variable


Definition


Immunosuppression long-term immunosuppressive therapy
Neurological dysfunction neurological disease severely affecting ambulation or day-to-day functioning
Active neoplasm malignant tumour present at operation
Active AIDS excluding HIV positive alone
Patient refuses blood products



Appendix G. Indication for surgery
Go

Variable


Definition


Emergency operation performed immediately on referral to surgeon or before the beginning of the next working day
Urgent operation performed at or after the beginning of the next working day but the patient must absolutely be kept in hospital before surgery
Elective all other operations
Recent myocardial infarction <3 months before operation, number of days specified
Postinfarction angina
Angina at rest
Unstable angina angina requiring intravenous nitrates until arrival in the operating room
Operation for catheter laboratory complication unplanned emergency arrival of the patient in the operating room after a catheter laboratory procedure
Left main coronary stenosis >50%, specify percentage
Number of diseased coronary vessels of left anterior descending, circumflex and right coronary arteries, >50% stenosis or occlusion, maximum of 3
Mitral regurgitation for mitral surgery
Mitral stenosis for mitral surgery
Systolic pulmonary artery pressure>60 for mitral surgery
Aortic regurgitation for aortic valve surgery
Aortic stenosis for aortic valve surgery
Aortic gradient >120 mmHg for aortic valve surgery
Acute active endocarditis

patient still under antibiotic treatment at time of surgery; specify number of weeks of intravenous treatment

Appendix H. Operative information
Go

Variable


Definition


Number of distal coronary anastomoses
Number of conduits
Number of mammary arteries
Number of saphenous conduits
If no mammary artery used specify if operative or preoperative decision
Mitral valve surgery specify commissurotomy, repair, mechanical, bioprosthesis, homograft
Aortic valve surgery specify commissurotomy, repair, mechanical, bioprosthesis, homograft
Tricuspid valve surgery specify repair or replacement
Ascending aortic replacement
Aortic root replacement including valve replacement and reimplantation of the coronary ostia
Aortic arch replacement any operation on the thoracic aorta needing deep hypothermic arrest or selective cerebral perfusion
Dissection any aortic surgery for acute dissection
Heart transplant
Heart–lung transplant
Atrial septal defect closure
Left ventricular aneurysmectomy
Postinfarction ventricular septal rupture closure
Pulmonary embolectomy
Other procedure not fully described

describe in full

Appendix I. Outcome
Go

Variable


Definition


Alive alive and discharged from hospital <30 days from date operation
Dead died within 30 days from operation or later than 30 days if still in hospital
Wait

patient still in hospital >30 days from operation: hold record and fill in as alive or dead when appropriate


    Appendix J. Conference discussion
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 Appendices A - I
 Appendix J. Conference...
 References
 
Dr J. Bachet (Suresnes, France): I would like to congratulate Dr Roques for this very important work. He coordinated this study and I am sure that it was a very difficult task. This is of most importance because more and more non-medical people are dealing with this type of information and dealing incorrectly with it. A few weeks ago in France a popular so-called ‘scientific’ paper published a sort of hit parade of hospitals, and especially the cardiac centres, with a methodology which was outrageous. The classification was taking into account only the whole mortality without any group of diseases, without scores of patients, et cetera, et cetera; it was devastating for the public, the hospitals and moreover the patients. So I believe that this kind of study should be sponsored by the national societies and perhaps also by the European Association for Cardio-thoracic Surgery in order to spread it to most centres. I understand indeed that you had 131 centres in your study. I guess that this represents a very small proportion of the European centres. Maybe through the Association we could promote this kind of scoring into most centres in Europe.

Dr F. Grover (Denver, CO): I chair the STS National Database Committee and want to congratulate you on your risk modelling, your statistical analysis and your effort. As you know, in the United States we found out the hard way, about 10 years ago, just as the previous discusser mentioned, what happens when other people analyse our data and do not risk stratify the data so that you have a level playing field. You have a problem when governmental and other organizations publish non-risk stratified data. I firmly believe in the importance of any effort that we can all make as an international community to risk stratify, and the importance of taking the risk of the patient into account ahead of time. It is also interesting how close your odds ratios are for the various preoperative risk factors to ours the STS Database.

Dr R. Dion (Brussels, Belgium): How did you select the centres and are you planning to include more centres in your study? We would be very keen in Belgium to participate in such a study.

Dr Roques: We chose the centres on a voluntary basis. We announced, in most countries by mailing, that we intended to do this study and lots of centres answered us. But of course yesterday Sam Nashef invited everybody who wants to use this score to go on and use it and to share the study with us. And I do agree with Mr Bachet saying that now national societies or even the European Society should help us in this work.

Dr B. Bridgewater (Manchester, UK): Two points first and then a question. We have looked at the predictive ability of some of the North American models to predict mortality following coronary artery surgery in the UK, and we found that the makeup of the population that we operate on is very different in terms of its preoperative characteristics to the USA population, and the North American risk models are not good when you subject them to statistical analysis. The second thing is, even within a small geographically defined region within the UK such as the northwest of England there are very big differences in patient characteristics between the different centres. So my question is, have you started to look in a structured way at the differences in preoperative characteristics across the large geographical area which is Europe and how do you think that might influence the ability of the model to predict mortality accurately in the different areas?

Dr Roques: Well, first of all, we had to analyse whether or not there were differences between North American results and European results. We have already worked on this subject in France four years ago and the study has been presented to you. Concerning regional particularity, of course we will not produce 10 or 12 or 100 scores all over Europe. We have to decide to use a score that will help every one of us to work, even if it does not take care of regional specificities. That is the reason why we have used an overall score concerning coronary surgery and valve surgery, because we know that in Europe some countries may still perform more valvular surgery than coronary surgery. That is the reason why we chose a global score.

Dr G. Rizzoli (Padua, Italy): The prevalence of the disease is changing quite rapidly. For instance, in Italy now, the mitral valve operation, which was more common among the valvular operations, has been superseded by the aortic valve, and the aortic is associated with coronary artery bypass. So I would like to know if you have special rules to take care of confounding from the prevalence of the different diseases when you prepare these studies?

Dr Roques: Well, we have tested every variable, we have tested 100 variables, and we decided to find a score, taking care of the major problems so as to create a global score. We considered any of the operative situations as valve surgery and coronary surgery, but we will not answer in detail to every specific problem. This is not the aim, this is not the purpose of our work. The purpose of the work is not to answer individual operative mortality assessment but rather to analyse quality of care for a centre, a country, in Europe.


    References
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 Appendices A - I
 Appendix J. Conference...
 References
 

  1. Warner C.D., Weintraub W.S., Craver J.M., Jones E.L., Gott J.P., Guyton R.A. Effect of cardiac surgery patient characteristics on patient outcomes from 1981 through 1995. Circulation 1997;96:1575-1579.[Abstract/Free Full Text]
  2. Roques F., Baudet E., David M., DeVincentiis C., Michel P., Gabrielle F. Quality of care in adult heart surgery: proposal for a self-assessment approach based on a French multicenter study. Eur J Cardiothorac Surg 1995;9:433-439.[Abstract]
  3. Pinna Pintor P., Bobbio M., Sandrelli L., Giammaria M., Patane F., Bartolozzi S., Bergandi G., Alfieri O. Risk stratification for open heart operations: comparison of centers regardless of the influence of the surgical team. Ann Thorac Surg 1997;64:410-413.[Abstract/Free Full Text]
  4. Parsonnet V., Dean D., Bernstein A.D. A method of uniform stratification of risk for evaluating the results of surgery in acquired heart disease. Circulation 1989;79(Suppl I):3-12.
  5. Higgins T.L., Estafanous F.G., Loop F.D., Beck G.J., Blum J.M., Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. J Am Med Assoc 1992;267:2344-2348.[Abstract/Free Full Text]
  6. Tuman K.J., McCarthy R.J., March R.J., Najafi H., Ivankovich A.D. Morbidity and duration of ICU stay after cardiac surgery: a model for preoperative risk assessment. Chest 1992;102:36-44.[Abstract/Free Full Text]
  7. Marshall G., Shroyer A.L.W., Grover F.L., Hammermeister K.E. Bayesian-logit model for risk assessment in coronary artery bypass grafting. Ann Thorac Surg 1994;57:1492-1500.[Abstract]
  8. Tremblay N.A., Hardy J.F., Perrault J., Carrier M. A simple classification of the risk in cardiac surgery: the first decade. Can J Anaesth 1993;40:103-111.[Medline]
  9. Tu J.V., Jaglal S.B., Naylor C.D. Multicenter validation of a risk index for mortality intensive care unit stay and overall hospital length of stay after cardiac surgery. Circulation 1995;91:677-684.[Abstract/Free Full Text]
  10. Edwards F.H., Bero J., Schwartz M., Shroyer A.L., Grover F.L. The Society of Thoracic Surgeons National Cardiac Surgery Database current risk assessment. Ann Thorac Surg 1997;63:903-908.[Abstract/Free Full Text]
  11. Higgins T.L., Estafanous F.G., Loop F.D., Beck G.J., Lee J.C., Starr N.J., Knaus W.A., Cosgrove D.M. ICU admission score for predicting morbidity and mortality risk after coronary artery bypass grafting. Ann Thorac Surg 1997;64:1050-1058.[Abstract/Free Full Text]
  12. Turner J.S., Morgan C.J., Thakrar B., Pepper J.R. Difficulties in predicting outcome in cardiac surgery patients. Crit Care Med 1995;23:1843-1850.[Medline]
  13. Tomasco B., Cappiello A., Fiorilli R., Leccese A., Lupino R., Romiti A., Tesler U.F. Surgical revascularisation for acute coronary insufficiency: analysis of risk factors for hospital mortality. Ann Thorac Surg 1997;64:678-683.[Abstract/Free Full Text]
  14. Parsonnet V., Bernstein A.D., Gera M. Clinical usefulness of risk-stratified outcome analysis in cardiac surgery in New Jersey. Ann Thorac Surg 1996;61(2 Suppl):S8-S11.
  15. Mark D.B. Implications of cost in treatment selection for patients with coronary disease. Ann Thorac Surg 1996;61:S12-S15.
  16. Sergeant P., Blackstone E., Meyns B. Validation and interdependence with patient variables of the influence of procedural variables on early and late survival after CABG. Eur J Cardiothorac Surg 1997;12:1-19.[Abstract]
  17. Sergeant P. (Discussion) of Roques F, Gabrielle F, Michel P, DeVincentiis C, David M, Baudet E. Quality of care in adult heart surgery: proposal for a self-assessment approach based on a French multicenter study. Eur J Cardiothorac Surg 1995;9:440.
  18. Brandrup-Wognsen G., Berggren H., Hartford M., Hjalmarson A., Karlsson T., Herlitz J. Female sex is associated with increased mortality and morbidity early but not late after coronary artery bypass grafting. Eur Heart J 1996;17:1426-1431.[Abstract/Free Full Text]
  19. Diewick M., Tandler R., Mollhoff T., Kerber S., Rotker J., Roeder N., Scheld H.H. Heart surgery in patients aged eighty years and above: determinants of morbidity and mortality. Thorac Cardiovasc Surg 1997;45:119-126.[Medline]
  20. Risum O., Abdelnoor M., Svennevig J.L., Levorstad K., Gullestad L., Bjornerheim R., Simonsen S., Nitter-Hauge S. Diabetes mellitus and morbidity and mortality risks after coronary artery bypass surgery. Scand J Thorac Cardiovasc Surg 1996;30:71-75.[Medline]
  21. Utley J.R., Leyland S.A., Fogarty C.M., Smith W.P., Knight E.B., Feldman G.J., Wilde E.F. Smoking is not a predictor of mortality and morbidity following coronary artery bypass grafting. J Card Surg 1996;11:377-384.[Medline]
  22. Redmond J.M., Greene P.S., Goldsborough M.A., Cameron D.E., Stuart R.S., Sussman M.S., Watkins L. Jr, Laschinger J.C., McKhann G.M., Johnston M.V., Baumgartner W.A. Neurologic injury in cardiac surgical patients with a history of stroke. Ann Thorac Surg 1996;61:42-47.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
HeartHome page
Y Li, Z Zheng, S Hu, and on behalf of the Chinese CABG Registry Study
The Chinese coronary artery bypass grafting registry study: analysis of the national multicentre database of 9248 patients
Heart, July 15, 2009; 95(14): 1140 - 1144.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
N. Messaoudi, J. De Cocker, B. A. Stockman, L. L. Bossaert, and I. E.R. Rodrigus
Is EuroSCORE useful in the prediction of extended intensive care unit stay after cardiac surgery?
Eur. J. Cardiothorac. Surg., July 1, 2009; 36(1): 35 - 39.
[Abstract] [Full Text] [PDF]


Home page
J Health Serv Res PolicyHome page
J. Jarvelin, G. Rosenqvist, U. Hakkinen, and H. Sintonen
Patient and hospital characteristics associated with claims and compensations for patient injuries in coronary artery bypass grafting in Finland
J Health Serv Res Policy, July 1, 2009; 14(3): 150 - 155.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. E. Greilich, M. E. Jessen, N. Satyanarayana, C. W. Whitten, G. A. Nuttall, J. M. Beckham, M. H. Wall, and J. F. Butterworth
The Effect of Epsilon-Aminocaproic Acid and Aprotinin on Fibrinolysis and Blood Loss in Patients Undergoing Primary, Isolated Coronary Artery Bypass Surgery: A Randomized, Double-Blind, Placebo-Controlled, Noninferiority Trial
Anesth. Analg., July 1, 2009; 109(1): 15 - 24.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Ranucci, S. Castelvecchio, L. Menicanti, A. Frigiola, and G. Pelissero
Risk of Assessing Mortality Risk in Elective Cardiac Operations: Age, Creatinine, Ejection Fraction, and the Law of Parsimony
Circulation, June 23, 2009; 119(24): 3053 - 3061.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Silberman, M. W. Klutstein, T. Sabag, A. Oren, D. Fink, O. Merin, and D. Bitran
Repair of Ischemic Mitral Regurgitation: Comparison Between Flexible and Rigid Annuloplasty Rings.
Ann. Thorac. Surg., June 1, 2009; 87(6): 1721 - 1727.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Al-Attar, D. Himbert, F. Descoutures, B. Iung, R. Raffoul, D. Messika-Zeitoun, E. Brochet, F. Francis, H. Ibrahim, A. Vahanian, et al.
Transcatheter Aortic Valve Implantation: Selection Strategy Is Crucial for Outcome.
Ann. Thorac. Surg., June 1, 2009; 87(6): 1757 - 1763.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
M. Carnero-Alcazar, A. Alswies, L. Perez-Isla, J. A. Silva-Guisasola, J. J. Gonzalez-Ferrer, F. Reguillo-Lacruz, J. L. Zamorano, and E. Rodriguez-Hernandez
Short-term and mid-term follow-up of sutureless surgery for postinfarction subacute free wall rupture
Interactive CardioVascular and Thoracic Surgery, June 1, 2009; 8(6): 619 - 623.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Leontyev, T. Walther, M. A. Borger, S. Lehmann, A. K. Funkat, A. Rastan, J. Kempfert, V. Falk, and F. W. Mohr
Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE.
Ann. Thorac. Surg., May 1, 2009; 87(5): 1440 - 1445.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Ailawadi, D. J. LaPar, B. R. Swenson, S. A. Siefert, C. Lau, J. A. Kern, B. B. Peeler, K. E. Littlewood, and I. L. Kron
Model for end-stage liver disease predicts mortality for tricuspid valve surgery.
Ann. Thorac. Surg., May 1, 2009; 87(5): 1460 - 1467.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
F. Versaci, B. Reimers, C. Del Giudice, J. Schofer, A. Giacomin, S. Sacca, R. Gandini, R. Albiero, A. Pellegrino, F. Bertoldo, et al.
Simultaneous Hybrid Revascularization by Carotid Stenting and Coronary Artery Bypass Grafting: The SHARP Study
J. Am. Coll. Cardiol. Intv., May 1, 2009; 2(5): 393 - 401.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Ranucci, A. Ballotta, A. Frigiola, A. Boncilli, S. Brozzi, E. Costa, and R. H. Mehta
Pre-operative homocysteine levels and morbidity and mortality following cardiac surgery
Eur. Heart J., April 2, 2009; 30(8): 995 - 1004.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
O. Birim, M. van Gameren, A. J.J.C. Bogers, P. W. Serruys, F. W. Mohr, and A. P. Kappetein
Complexity of Coronary Vasculature Predicts Outcome of Surgery for Left Main Disease
Ann. Thorac. Surg., April 1, 2009; 87(4): 1097 - 1105.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. M. Calafiore, S. Gallina, A. L. Iaco, M. Contini, A. Bivona, M. Gagliardi, P. Bosco, and M. Di Mauro
Mitral Valve Surgery for Functional Mitral Regurgitation: Should Moderate-or-More Tricuspid Regurgitation Be Treated? A Propensity Score Analysis.
Ann. Thorac. Surg., March 1, 2009; 87(3): 698 - 703.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
V. Svircevic, A. P. Nierich, K. G. M. Moons, G. J. Brandon Bravo Bruinsma, C. J. Kalkman, and D. van Dijk
Fast-Track Anesthesia and Cardiac Surgery: A Retrospective Cohort Study of 7989 Patients
Anesth. Analg., March 1, 2009; 108(3): 727 - 733.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
D. L. Ngaage, M. E. Cowen, and A. R. Cale
Cardiopulmonary bypass and left ventricular systolic dysfunction impacts operative mortality differently in elderly and young patients
Eur. J. Cardiothorac. Surg., February 1, 2009; 35(2): 235 - 240.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Parolari, L. L. Pesce, M. Trezzi, C. Loardi, S. Kassem, C. Brambillasca, B. Miguel, E. Tremoli, P. Biglioli, and F. Alamanni
Performance of EuroSCORE in CABG and off-pump coronary artery bypass grafting: single institution experience and meta-analysis
Eur. Heart J., February 1, 2009; 30(3): 297 - 304.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Z. Zheng, Y. Li, S. Zhang, S. Hu, and on behalf of the Chinese CABG Registry Study
The Chinese Coronary Artery Bypass Grafting Registry Study: how well does the EuroSCORE predict operative risk for Chinese population?
Eur. J. Cardiothorac. Surg., January 1, 2009; 35(1): 54 - 58.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. K. Choong, P. Sergeant, S. A.M. Nashef, J. A. Smith, and B. Bridgewater
Editorial comment: The EuroSCORE risk stratification system in the current era: how accurate is it and what should be done if it is inaccurate?
Eur. J. Cardiothorac. Surg., January 1, 2009; 35(1): 59 - 61.
[Full Text] [PDF]


Home page
Eur Heart JHome page
B. R. Osswald, V. Gegouskov, D. Badowski-Zyla, U. Tochtermann, G. Thomas, S. Hagl, and E. H. Blackstone
Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement
Eur. Heart J., January 1, 2009; 30(1): 74 - 80.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Koster, F. G.J. Oosterveld, A. G. Hensens, A. Wijma, and J. van der Palen
Delirium After Cardiac Surgery and Predictive Validity of a Risk Checklist
Ann. Thorac. Surg., December 1, 2008; 86(6): 1883 - 1887.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Ranucci, G. Bozzetti, A. Ditta, M. Cotza, G. Carboni, and A. Ballotta
Surgical Reexploration After Cardiac Operations: Why a Worse Outcome?
Ann. Thorac. Surg., November 1, 2008; 86(5): 1557 - 1562.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
W. Dietrich, M. Spannagl, J. Boehm, K. Hauner, S. Braun, T. Schuster, and R. Busley
Tranexamic Acid and Aprotinin in Primary Cardiac Operations: An Analysis of 220 Cardiac Surgical Patients Treated with Tranexamic Acid or Aprotinin
Anesth. Analg., November 1, 2008; 107(5): 1469 - 1478.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Zierer, G. Wimmer-Greinecker, S. Martens, A. Moritz, and M. Doss
The transapical approach for aortic valve implantation.
J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 948 - 953.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Biancari, M. A. A. Mahar, M. Mosorin, J. Heikkinen, M. Pokela, P. Taskinen, V. Anttila, J. Lahtinen, and M. Lepojarvi
Immediate and Intermediate Outcome After Off-Pump and On-Pump Coronary Artery Bypass Surgery in Patients With Unstable Angina Pectoris
Ann. Thorac. Surg., October 1, 2008; 86(4): 1147 - 1152.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Musci, A. Loforte, E. V. Potapov, T. Krabatsch, Y. Weng, M. Pasic, and R. Hetzer
Body Mass Index and Outcome After Ventricular Assist Device Placement
Ann. Thorac. Surg., October 1, 2008; 86(4): 1236 - 1242.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
W. Rademacher, A. Knape, J. Schumm, M. Ferrari, A. Lauten, H. Mudra, and H. R. Figulla
Acute and long-term outcome of unprotected left main coronary angioplasty compared to the anticipated surgical risk
Interactive CardioVascular and Thoracic Surgery, October 1, 2008; 7(5): 871 - 877.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. L. Brown, H. V. Schaff, M. E. Sarano, Z. Li, T. M. Sundt, J. A. Dearani, C. J. Mullany, and T. A. Orszulak
Is the European System for Cardiac Operative Risk Evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement?
J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 566 - 571.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. Luciani, A. Anselmi, R. De Geest, L. Martinelli, M. Perisano, and G. Possati
Extracorporeal circulation by peripheral cannulation before redo sternotomy: Indications and results
J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 572 - 577.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
J. Granton and D. Cheng
Risk Stratification Models for Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2008; 12(3): 167 - 174.
[Abstract] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
A. A. Klein and S. A. M. Nashef
Perception and Reporting of Cardiac Surgical Performance
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2008; 12(3): 184 - 190.
[Abstract] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Massoudy, S. Wagner, M. Thielmann, U. Herold, E. Kottenberg-Assenmacher, G. Marggraf, A. Kribben, T. Philipp, H. Jakob, and S. Herget-Rosenthal
Coronary artery bypass surgery and acute kidney injury--impact of the off-pump technique
Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2853 - 2860.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
P. T.L. Chiam and C. E. Ruiz
Percutaneous Transcatheter Aortic Valve Implantation: Assessing Results, Judging Outcomes, and Planning Trials: The Interventionalist Perspective
J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 341 - 350.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S W Grant, A D Grayson, M Jackson, J Au, B M Fabri, G Grotte, M Jones, and B Bridgewater
Does the choice of risk-adjustment model influence the outcome of surgeon-specific mortality analysis? A retrospective analysis of 14 637 patients under 31 surgeons
Heart, August 1, 2008; 94(8): 1044 - 1049.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Di Mauro and A. M. Calafiore
Reply
Ann. Thorac. Surg., July 1, 2008; 86(1): 350 - 350.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. A. den Uil, W. K. Lagrand, P. E. Spronk, R. T. van Domburg, J. Hofland, C. Luthen, J. J. Brugts, M. van der Ent, and M. L. Simoons
Impaired sublingual microvascular perfusion during surgery with cardiopulmonary bypass: A pilot study
J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 129 - 134.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
B Bridgewater and B Keogh
Surgical "league tables"
Heart, July 1, 2008; 94(7): 936 - 942.
[Full Text] [PDF]


Home page
QJMHome page
P. Kojodjojo, N. Gohil, D. Barker, P. Youssefi, T.V. Salukhe, A. Choong, M. Koa-Wing, J. Bayliss, D.R. Hackett, and M.A. Khan
Outcomes of elderly patients aged 80 and over with symptomatic, severe aortic stenosis: impact of patient's choice of refusing aortic valve replacement on survival
QJM, July 1, 2008; 101(7): 567 - 573.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Dunning, J. R.L. Waller, B. Smith, S. Pitts, S. W.H. Kendall, and K. Khan
Coronary Artery Bypass Grafting is Associated With Excellent Long-Term Survival and Quality of Life: A Prospective Cohort Study
Ann. Thorac. Surg., June 1, 2008; 85(6): 1988 - 1993.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol IntvHome page
N. Piazza, Y. Onuma, E. Jesserun, P. P. Kint, A.-M. Maugenest, R. H. Anderson, P. P. T. de Jaegere, and P. W. Serruys
Early and Persistent Intraventricular Conduction Abnormalities and Requirements for Pacemaking After Percutaneous Replacement of the Aortic Valve
J. Am. Coll. Cardiol. Intv., June 1, 2008; 1(3): 310 - 316.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Sachithanandan, P. Nanjaiah, P. Nightingale, I. C. Wilson, T. R. Graham, S. J. Rooney, B. E. Keogh, and D. Pagano
Deep sternal wound infection requiring revision surgery: impact on mid-term survival following cardiac surgery
Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 673 - 678.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. Merello, E. Riesle, J. Alburquerque, H. Torres, E. Aranguiz-Santander, O. Pedemonte, and B. Westerberg
Risk Scores Do Not Predict High Mortality After Coronary Artery Bypass Surgery in the Presence of Diastolic Dysfunction
Ann. Thorac. Surg., April 1, 2008; 85(4): 1247 - 1255.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. van Gameren, A. P. Kappetein, E. W. Steyerberg, A. C. Venema, E. A.J. Berenschot, E. L. Hannan, A. J.J.C. Bogers, and J. J.M. Takkenberg
Do We Need Separate Risk Stratification Models for Hospital Mortality After Heart Valve Surgery?
Ann. Thorac. Surg., March 1, 2008; 85(3): 921 - 930.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
L. A. Menicanti
The surgeon, the statistics and the data
Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 323 - 324.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. D'Errigo, F. Seccareccia, S. Rosato, V. Manno, G. Badoni, D. Fusco, C. A. Perucci, and the Research Group of the Italian CABG Outcome Pro
Comparison between an empirically derived model and the EuroSCORE system in the evaluation of hospital performance: the example of the Italian CABG Outcome Project
Eur. J. Cardiothorac. Surg., March 1, 2008; 33(3): 325 - 333.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
G. Silvay, J. G. Castillo, J. Chikwe, B. Flynn, and F. Filsoufi
Cardiac Anesthesia and Surgery in Geriatric Patients
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2008; 12(1): 18 - 28.
[Abstract] [PDF]


Home page
NEJMHome page
S. Schneeweiss, J. D. Seeger, J. Landon, and A. M. Walker
Aprotinin during Coronary-Artery Bypass Grafting and Risk of Death
N. Engl. J. Med., February 21, 2008; 358(8): 771 - 783.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Ranucci, A. Pazzaglia, C. Bianchini, G. Bozzetti, and G. Isgro
Body Size, Gender, and Transfusions as Determinants of Outcome After Coronary Operations
Ann. Thorac. Surg., February 1, 2008; 85(2): 481 - 486.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Z. Colak, I. Segotic, S. Uzun, M. Mazar, V. Ivancan, and V. Majeric-Kogler
Health related quality of life following cardiac surgery correlation with EuroSCORE
Eur. J. Cardiothorac. Surg., January 1, 2008; 33(1): 72 - 76.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. Deneke, K. Khargi, B. Lemke, T. Lawo, M. Lindstaedt, A. Germing, T. Brodherr, L. Bosche, A. Mugge, A. Laczkovics, et al.
Intra-operative cooled-tip radiofrequency linear atrial ablation to treat permanent atrial fibrillation
Eur. Heart J., December 1, 2007; 28(23): 2909 - 2914.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
S Green and E Aird
Imaging in radiotherapy
Br. J. Radiol., December 1, 2007; 80(960): 967 - 969.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Versaci, C. Del Giudice, A. Scafuri, J. Zeitani, R. Gandini, P. Nardi, A. Salvati, E. Pampana, F. Sebastiano, A. Romagnoli, et al.
Sequential Hybrid Carotid and Coronary Artery Revascularization: Immediate and Mid-Term Results
Ann. Thorac. Surg., November 1, 2007; 84(5): 1508 - 1514.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
P. J. Van der Linden, J.-F. Hardy, A. Daper, A. Trenchant, and S. G. De Hert
Cardiac surgery with cardiopulmonary bypass: does aprotinin affect outcome?
Br. J. Anaesth., November 1, 2007; 99(5): 646 - 652.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
A. Szekely, P. Balog, E. Benko, T. Breuer, J. Szekely, M. D. Kertai, F. Horkay, M. S. Kopp, and J. F. Thayer
Anxiety Predicts Mortality and Morbidity After Coronary Artery and Valve Surgery A 4-Year Follow-Up Study
Psychosom Med, September 1, 2007; 69(7): 625 - 631.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. A. Mestres, M. A. Castro, E. Bernabeu, M. Josa, R. Cartana, J. L. Pomar, J. M. Miro, J. Mulet, and the Hospital Clinico Endocarditis Study Group
Preoperative risk stratification in infective endocarditis. Does the EuroSCORE model work? Preliminary results
Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 281 - 285.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. Bakhtiary, P. Therapidis, O. Dzemali, K. Ak, H. Ackermann, D. Meininger, P. Kessler, P. Kleine, A. Moritz, T. Aybek, et al.
Impact of high thoracic epidural anesthesia on incidence of perioperative atrial fibrillation in off-pump coronary bypass grafting: A prospective randomized study
J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 460 - 464.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Gaudino, F. Girola, M. Piscitelli, L. Martinelli, A. Anselmi, C. Della Vella, R. Schiavello, and G. Possati
Long-term survival and quality of life of patients with prolonged postoperative intensive care unit stay: Unmasking an apparent success
J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 465 - 469.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. Ledoux, M. Monchi, J.-P. Chapelle, and P. Damas
Cystatin C blood level as a risk factor for death after heart surgery
Eur. Heart J., August 1, 2007; 28(15): 1848 - 1853.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Grube, L. Buellesfeld, U. Gerckens, R. Mueller, M. Menichelli, T. Schmidt, J. C. Laborde, T. Felderhoff, S. Iversen, B. Sauren, et al.
Response to Letter Regarding Article, "Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study"
Circulation, June 5, 2007; 115(22): e613 - e613.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y.-N. Youn, Y.-L. Kwak, and K.-J. Yoo
Can the EuroSCORE Predict the Early and Mid-Term Mortality After Off-Pump Coronary Artery Bypass Grafting?
Ann. Thorac. Surg., June 1, 2007; 83(6): 2111 - 2117.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Y. Lamarche, L. P. Perrault, S. Maltais, K. Tetreault, J. Lambert, and A. Y. Denault
Preliminary experience with inhaled milrinone in cardiac surgery
Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1081 - 1087.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Mirabel, B. Iung, G. Baron, D. Messika-Zeitoun, D. Detaint, J.-L. Vanoverschelde, E. G. Butchart, P. Ravaud, and A. Vahanian
What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery?
Eur. Heart J., June 1, 2007; 28(11): 1358 - 1365.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
B. Bridgewater, A. D Grayson, N. Brooks, G. Grotte, B. M Fabri, J. Au, T. Hooper, M. Jones, B. Keogh, and on behalf of the North West Quality Improvement Pr
Has the publication of cardiac surgery outcome data been associated with changes in practice in northwest England: an analysis of 25 730 patients undergoing CABG surgery under 30 surgeons over eight years
Heart, June 1, 2007; 93(6): 744 - 748.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. S. Adabag, T. Rector, S. Mithani, J. Harmala, H. B. Ward, R. F. Kelly, J. T. Nguyen, E. O. McFalls, and H. E. Bloomfield
Prognostic Significance of Elevated Cardiac Troponin I After Heart Surgery
Ann. Thorac. Surg., May 1, 2007; 83(5): 1744 - 1750.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Paul, A. Raz, L. Leibovici, H. Madar, R. Holinger, and B. Rubinovitch
Sternal wound infection after coronary artery bypass graft surgery: Validation of existing risk scores
J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 397 - 403.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Valgimigli, K. Dawkins, C. Macaya, B. de Bruyne, E. Teiger, J. Fajadet, R. Gert, S. De Servi, A. Ramondo, K. Wittebols, et al.
Impact of Stable Versus Unstable Coronary Artery Disease on 1-Year Outcome in Elective Patients Undergoing Multivessel Revascularization With Sirolimus-Eluting Stents: A Subanalysis of the ARTS II Trial
J. Am. Coll. Cardiol., January 30, 2007; 49(4): 431 - 441.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, G. Filippatos, F. Flachskampf, R. Hall, B. Iung, et al.
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology
Eur. Heart J., January 26, 2007; (2007) ehl428v1.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Walther, V. Falk, M. A. Borger, T. Dewey, G. Wimmer-Greinecker, G. Schuler, M. Mack, and F. W. Mohr
Minimally invasive transapical beating heart aortic valve implantation -- proof of concept
Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 9 - 15.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F Bhatti, A D Grayson, G Grotte, B M Fabri, J Au, M Jones, B Bridgewater, and on behalf of the North West Quality Improvement Pr
The logistic EuroSCORE in cardiac surgery: how well does it predict operative risk?
Heart, December 1, 2006; 92(12): 1817 - 1820.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
S. Gunaydin, K. McCusker, V. Vijay, S. Isbir, T. Sari, M. A. Onur, A. Gurpinar, A. Sezgin, M. F Sargon, T. Tezcaner, et al.
Comparison of polymethoxyethylacrylate-coated circuits with leukocyte filtration and reduced heparinization protocol on heparin-bonded circuits in different risk cohorts
Perfusion, November 1, 2006; 21(6): 329 - 342.
[Abstract] [PDF]


Home page
CirculationHome page
E. Grube, J. C. Laborde, U. Gerckens, T. Felderhoff, B. Sauren, L. Buellesfeld, R. Mueller, M. Menichelli, T. Schmidt, B. Zickmann, et al.
Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease: The Siegburg First-in-Man Study
Circulation, October 10, 2006; 114(15): 1616 - 1624.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. L. Croal, G. S. Hillis, P. H. Gibson, M. T. Fazal, H. El-Shafei, G. Gibson, R. R. Jeffrey, K. G. Buchan, D. West, and B. H. Cuthbertson
Relationship Between Postoperative Cardiac Troponin I Levels and Outcome of Cardiac Surgery
Circulation, October 3, 2006; 114(14): 1468 - 1475.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Nishida, M. Masuda, Y. Tomita, S. Tokunaga, Y. Tanoue, A. Shiose, S. Morita, and R. Tominaga
The logistic EuroSCORE predicts the hospital mortality of the thoracic aortic surgery in consecutive 327 Japanese patients better than the additive EuroSCORE.
Eur. J. Cardiothorac. Surg., October 1, 2006; 30(4): 578 - 582.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
R. Salem, A. Y. Denault, P. Couture, S. Belisle, A. Fortier, M.-C. Guertin, M. Carrier, and R. Martineau
Left ventricular end-diastolic pressure is a predictor of mortality in cardiac surgery independently of left ventricular ejection fraction
Br. J. Anaesth., September 1, 2006; 97(3): 292 - 297.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
N. Hudorovic
Reduction in hospitalisation rates following simultaneous carotid endarterectomy and coronary artery bypass grafting; experience from a single centre
Interactive CardioVascular and Thoracic Surgery, August 1, 2006; 5(4): 367 - 372.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. J. Leavitt, C. S. Ross, B. Spence, S. D. Surgenor, E. M. Olmstead, R. A. Clough, D. C. Charlesworth, R. S. Kramer, G. T. O'Connor, and for the Northern New England Cardiovascular Diseas
Long-Term Survival of Patients With Chronic Obstructive Pulmonary Disease Undergoing Coronary Artery Bypass Surgery
Circulation, July 4, 2006; 114(1_suppl): I-430 - I-434.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Walther, A. Rastan, V. Falk, S. Lehmann, J. Garbade, A. K. Funkat, F. W. Mohr, and J. F. Gummert
Patient prosthesis mismatch affects short- and long-term outcomes after aortic valve replacement.
Eur. J. Cardiothorac. Surg., July 1, 2006; 30(1): 15 - 19.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Nilsson, M. Ohlsson, L. Thulin, P. Hoglund, S. A.M. Nashef, and J. Brandt
Risk factor identification and mortality prediction in cardiac surgery using artificial neural networks
J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 12 - 19.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
N. Chaudhuri, J. James, A. Sheikh, A. D. Grayson, and B. M. Fabri
Intestinal ischaemia following cardiac surgery: a multivariate risk model.
Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 971 - 977.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C.-J. Jakobsen, P. Torp, and E. Sloth
Assessment of left ventricular ejection fraction may invalidate the reliability of EuroSCORE.
Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 978 - 982.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Matsuura, H. Ogino, H. Matsuda, K. Minatoya, H. Sasaki, T. Yagihara, and S. Kitamura
Limitations of EuroSCORE for Measurement of Risk-Stratified Mortality in Aortic Arch Surgery Using Selective Cerebral Perfusion: Is Advanced Age No Longer a Risk?
Ann. Thorac. Surg., June 1, 2006; 81(6): 2084 - 2087.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Walther, T. Dewey, G. Wimmer-Greinecker, M. Doss, R. Hambrecht, G. Schuler, F. W. Mohr, and M. Mack
Transapical approach for sutureless stent-fixed aortic valve implantation: experimental results.
Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 703 - 708.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
K. Hekmat, U. Mehlhorn, and T. Wahlers
Do we need the new Italian risk stratification model for CABG patients?
Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 856 - 857.
[Full Text] [PDF]


Home page
Eur Heart JHome page
M. Cladellas, J. Bruguera, J. Comin, J. Vila, E. de Jaime, J. Marti, and M. Gomez
Is pre-operative anaemia a risk marker for in-hospital mortality and morbidity after valve replacement?
Eur. Heart J., May 1, 2006; 27(9): 1093 - 1099.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Valgimigli, P. Malagutti, G. A. Rodriguez-Granillo, H. M. Garcia-Garcia, J. Polad, K. Tsuchida, E. Regar, W. J. Van der Giessen, P. de Jaegere, P. De Feyter, et al.
Distal Left Main Coronary Disease Is a Major Predictor of Outcome in Patients Undergoing Percutaneous Intervention in the Drug-Eluting Stent Era: An Integrated Clinical and Angiographic Analysis Based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) Registries
J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1530 - 1537.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roques, F.
Right arrow Articles by Thulin, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roques, F.
Right arrow Articles by Thulin, L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS